RS

Reliance, Inc.

$357.49

-0.70%
May 19, 2026
Bobby Quantitative Model
Reliance, Inc. is a leading metals service center company operating in the Steel industry within the Basic Materials sector, distributing a vast portfolio of over 100,000 metal products to more than 125,000 customers across diverse industries such as aerospace, construction, and manufacturing. The company is a prominent player in the fragmented metals distribution market, distinguished by its extensive network, diversified product line, and value-added toll processing services. The current investor narrative is likely focused on navigating cyclical demand headwinds and commodity price volatility, as evidenced by its recent appearance in a list of large-cap losers, which suggests the stock is sensitive to broader market sentiment and specific earnings-related pressures within the industrial sector.

People also watch

Nucor

Nucor

NUE

Analysis
Steel Dynamics

Steel Dynamics

STLD

Analysis
Commercial Metals Company

Commercial Metals Company

CMC

Analysis
Cleveland-Cliffs

Cleveland-Cliffs

CLF

Analysis
Southern Copper Corporation

Southern Copper Corporation

SCCO

Analysis

BobbyInvestment Opinion: Should I buy RS Today?

Rating & Thesis: Hold. RS presents a balanced but uncertain risk/reward profile; it is a cyclical stock with a strong foundation, priced for a recovery that is not yet proven. The lack of a broad analyst consensus and price target prevents a clear upside calculation, anchoring the view to caution.

Supporting Evidence: The recommendation is supported by four key data points: 1) The attractive forward P/E of 17.34x suggests the market is not overpaying for growth, 2) The exceptionally strong balance sheet (D/E 0.28) provides a margin of safety, 3) The stock's 20.28% one-year gain and strong technical momentum indicate positive price action, yet 4) The extreme volatility in earnings (trailing EPS $0.05 vs. forward $17.39) creates high uncertainty about the fundamental outlook. The valuation appears fair, not cheap, given the embedded recovery assumptions.

Risks & Conditions: The two biggest risks are a failure to achieve the forward EPS of $17.39 and a broader economic slowdown impacting industrial demand. This Hold rating would upgrade to a Buy if quarterly results begin to confirm the earnings recovery trajectory, pushing the stock sustainably above the $381 resistance. It would downgrade to a Sell if earnings significantly disappoint or if the technical structure breaks down below key support near $300. Relative to its own projected recovery, the stock is fairly valued; it is neither clearly overvalued nor undervalued without more concrete evidence of the cyclical upturn.

Sign up to view all

RS 12-Month Price Forecast

The outlook for RS is a coin flip on the cyclical recovery. The company's financial health is excellent, and the valuation is reasonable if the earnings rebound materializes. However, the stock has already priced in much of this optimism, trading near its highs. The lack of analyst consensus adds to the uncertainty. The stance is neutral with medium confidence, as the path depends almost entirely on macroeconomic and industrial demand factors outside the company's control. The stance would upgrade to bullish on confirmation of the earnings recovery in the next two quarterly reports, or downgrade to bearish on a breakdown below key technical support near $300.

Historical Price
Current Price $357.49
Average Target $360
High Target $420
Low Target $260

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Reliance, Inc.'s 12-month outlook, with a consensus price target around $464.74 and implied upside of +30.0% versus the current price.

Average Target

$464.74

1 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

1

covering this stock

Price Range

$286 - $465

Analyst target range

Buy
0 (0%)
Hold
0 (0%)
Sell
1 (100%)

Analyst coverage for Reliance, Inc. is extremely limited, with only one analyst providing estimates, which indicates this is likely a smaller or less-followed name within the institutional investment community, leading to potentially higher volatility and less efficient price discovery. The single analyst provides an estimated EPS range of $16.89 to $17.92, with an average of $17.39, and an estimated revenue range of $14.83 billion to $15.52 billion; the narrow range for EPS suggests some conviction in the earnings forecast, but the overall lack of a consensus price target or recommendation distribution prevents any calculation of implied upside or meaningful sentiment analysis.

Drowning in data?

Find the real signal!

Bulls vs Bears: RS Investment Factors

The bull case for RS is anchored in its fortress-like balance sheet, attractive forward valuation, and strong technical momentum. The bear case centers on its extreme cyclicality, dependence on a massive earnings recovery, and limited analyst support. Currently, the bullish evidence appears stronger, driven by the powerful combination of low leverage and a discounted forward multiple pricing in a sharp cyclical rebound. The single most important tension in the investment debate is whether the company can deliver on the forward EPS estimate of $17.39. If achieved, the stock is undervalued; if missed, the valuation thesis collapses, likely triggering a significant decline.

Bullish

  • Strong Balance Sheet & Low Leverage: The company maintains a robust current ratio of 4.88, indicating ample liquidity to navigate downturns. Furthermore, its debt-to-equity ratio of 0.28 is exceptionally low, providing significant financial flexibility and resilience against rising interest rates.
  • Attractive Forward Valuation: The stock trades at a forward P/E of 17.34x, a discount to its trailing P/E of 20.53x, implying the market expects significant earnings growth. The forward EPS estimate of $17.39 is substantially higher than the trailing EPS of $0.05, suggesting a sharp recovery in profitability is anticipated.
  • Sustained Technical Uptrend: The stock has gained 20.28% over the past year and 33.87% over the past six months, demonstrating strong momentum. It is currently trading at $361.73, near the upper end of its 52-week range ($260.31 to $381.00), indicating persistent bullish pressure.
  • Moderate Profitability & Efficiency: The company generates a net margin of 5.17% and an operating margin of 7.15%, which are reasonable for a low-margin distribution business. Its Return on Equity of 10.31% and Return on Assets of 6.74% indicate moderate efficiency in utilizing its capital base.

Bearish

  • Extreme Cyclical & Earnings Volatility: The massive discrepancy between trailing EPS ($0.05) and forward EPS estimate ($17.39) highlights extreme earnings volatility inherent to the metals distribution business. This cyclicality makes forecasting difficult and exposes the stock to sharp corrections during industrial downturns.
  • Limited Analyst Coverage & Sentiment: Only one analyst provides estimates, indicating the stock is underfollowed by the institutional community. This lack of consensus leads to less efficient price discovery and potentially higher volatility, as seen in its recent appearance on a list of large-cap losers.
  • Valuation Dependent on Sharp Recovery: The forward P/E of 17.34x is only attractive if the projected earnings surge materializes. A failure to meet the $17.39 EPS estimate would cause significant multiple compression, given the stock's current price is anchored to this optimistic forward outlook.
  • Proximity to 52-Week High Resistance: The stock is trading just 5.1% below its 52-week high of $381.00, a key technical resistance level. Recent price action shows volatility, with a 22.62% max drawdown from the February peak, suggesting the uptrend may be overextended and vulnerable to a pullback.

RS Technical Analysis

The stock is in a sustained uptrend over the past year, evidenced by a 20.28% price increase, and is currently trading near the upper end of its 52-week range, approximately 73% of the way from its low of $260.31 to its high of $381.00, indicating strong momentum but also proximity to a key resistance level that could signal overextension. Recent short-term momentum is exceptionally strong, with a 13.07% gain over the past month, which significantly outpaces the 5.33% gain over the past three months, suggesting a recent acceleration in bullish sentiment that diverges from a more moderate intermediate-term trend; this is further supported by a 1-month relative strength of +7.47% against the SPY. Key technical support is anchored at the 52-week low of $260.31, while immediate resistance sits at the 52-week high of $381.00; a decisive breakout above $381 would confirm the uptrend's strength, whereas a failure could lead to a consolidation phase, with the stock's beta of 0.948 indicating its volatility is marginally lower than the broader market, which is notable for a cyclical materials company.

Beta

0.95

0.95x market volatility

Max Drawdown

-22.6%

Largest decline past year

52-Week Range

$260-$381

Price range past year

Annual Return

+17.4%

Cumulative gain past year

PeriodRS ReturnS&P 500
1m+9.8%+3.3%
3m+6.3%+6.9%
6m+33.9%+12.4%
1y+17.4%+23.4%
ytd+20.8%+7.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

RS Fundamental Analysis

Revenue trajectory analysis is constrained as specific quarterly revenue and growth rate figures are not available in the provided data, preventing a detailed assessment of whether growth is accelerating or decelerating; however, the estimated revenue average for the upcoming period is $15.16 billion, which provides a forward-looking benchmark for future performance evaluation. The company is profitable with a trailing EPS of $0.05 and a net margin of 5.17%, while its gross margin stands at 26.79% and operating margin at 7.15%; these margin levels are critical for a low-margin distribution business, but without multi-quarter data, the trend of margin expansion or compression cannot be determined. The balance sheet appears healthy with a strong current ratio of 4.88 and a conservative debt-to-equity ratio of 0.28, indicating ample liquidity and low financial leverage; the Return on Equity (ROE) of 10.31% and Return on Assets (ROA) of 6.74% suggest moderate efficiency in generating profits from its capital base.

Quarterly Revenue

N/A

N/A

Revenue YoY Growth

N/A

YoY Comparison

Gross Margin

N/A

Latest Quarter

Free Cash Flow

N/A

Last 12 Months

Open an Account, get $2 TSLA now!

Valuation Analysis: Is RS Overvalued?

Given the positive net income and EPS, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 20.53x and a forward P/E of 17.34x; the lower forward multiple implies the market anticipates earnings growth, as the forward estimate of $17.39 is substantially higher than the trailing figure. Peer comparison is limited as industry average multiples are not provided in the data; however, the stock's Price-to-Sales (P/S) ratio of 1.06 and EV/Sales of 1.39 can be used as sector context, though a definitive premium or discount assessment cannot be quantified without benchmark data. Historical context for the valuation is also unavailable due to missing historical ratios data, preventing an analysis of whether the current P/E is near the top or bottom of its own historical range, which limits the ability to gauge if the stock is priced for optimistic expectations or presents a value opportunity.

PE

20.5x

Latest Quarter

vs. Historical

N/A

5-Year PE Range 17x~59x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

13.0x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: The primary financial risk is earnings volatility, as evidenced by the chasm between trailing EPS ($0.05) and forward estimates ($17.39). This cyclicality is inherent to the metals distribution business, which is sensitive to industrial demand and commodity prices. While the balance sheet is strong (D/E of 0.28, Current Ratio of 4.88), a prolonged downturn could pressure the 5.17% net margin and challenge the anticipated earnings recovery. Revenue concentration is mitigated by a diversified customer base of over 125,000 clients, but the entire business remains exposed to the macroeconomic cycle.

Market & Competitive Risks: The stock's valuation (forward P/E of 17.34x) is entirely predicated on a sharp earnings recovery. If growth expectations falter, the multiple is at risk of significant compression. The stock's beta of 0.948 indicates it moves nearly in line with the market, offering little defensive quality during broad sell-offs. Competitive risks stem from operating in a fragmented industry, though its scale and extensive product portfolio (100,000+ SKUs) provide some moat. Recent news highlighting it as a 'large-cap loser' underscores its vulnerability to earnings-related sentiment shifts and sector rotation away from cyclicals.

Worst-Case Scenario: The worst-case scenario involves a severe industrial recession leading to a collapse in metal demand and pricing. This would cause the anticipated earnings recovery to fail, resulting in multiple compression and a flight to safety. The realistic downside could see the stock re-test its 52-week low of $260.31, representing a -28% decline from the current price of $361.73. The historical max drawdown of -22.62% from recent highs provides a precedent for such volatility. In this adverse scenario, an investor could face a loss of 25-30% as the cyclical downturn narrative overwhelms the strong balance sheet story.

FAQ

The key risks are, in order of severity: 1) Cyclical/Earnings Risk: The business is highly volatile, with EPS swinging from $0.05 to an estimated $17.39; a downturn would crush the valuation thesis. 2) Execution Risk: The company must deliver on the forward EPS estimate to justify its current price; any miss could lead to a sharp decline. 3) Market Risk: The stock has a beta of 0.948 and is correlated to the broader market, offering little defense in a bear market. 4) Sentiment & Coverage Risk: With only one analyst providing estimates, the stock is prone to sentiment-driven swings and less efficient price discovery, as seen when it recently appeared on a list of large-cap losers.

The 12-month forecast is bifurcated based on the success of the earnings recovery. The base case (50% probability) sees the stock trading between $340 and $380 as it meets the average EPS estimate of $17.39. The bull case (30% probability) targets $381 to $420+ if earnings exceed expectations and the stock breaks out. The bear case (20% probability) warns of a drop to $260-$300 if the recovery falters and the stock retests its lows. The most likely scenario is the base case, contingent on the assumption that industrial demand remains stable enough for the company to hit its earnings targets.

Based on current data, RS appears fairly valued. The trailing P/E of 20.53x is not meaningful due to depressed trailing earnings. The forward P/E of 17.34x is the relevant metric, and it prices in a substantial earnings recovery. Without industry average P/E data for a direct peer comparison, the valuation is neither a clear premium nor discount. The market is paying a fair price for the company's projected earnings normalization and its strong financial position, implying expectations for a cyclical upturn without excessive optimism.

RS is a conditional buy for investors comfortable with cyclical industrial stocks. The forward P/E of 17.34x is reasonable if the projected EPS of $17.39 is achieved, and the strong balance sheet (debt-to-equity 0.28) limits downside risk. However, it is not a good buy for risk-averse investors, as the stock is highly sensitive to economic cycles, has limited analyst coverage, and is trading near its 52-week high. It could be a good buy on a pullback towards $320-$340 for those believing in a sustained industrial recovery.

RS is more suitable for a medium- to long-term investment horizon of at least 12-18 months. This timeframe allows for the anticipated industrial cycle and earnings recovery to play out. The stock's beta of 0.948 and cyclical nature make it a poor candidate for short-term trading, as it can experience significant volatility, evidenced by a 22.62% max drawdown from recent highs. It does not pay a significant dividend (yield 1.68%) to support an income strategy. Investors should be prepared to hold through potential volatility to realize the gains of the recovery thesis.